ClinicalTrials.Veeva

Menu

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Tobacco Use Cessation

Treatments

Other: Patient Outcomes
Other: Billing documentation
Other: Regulatory

Study type

Observational

Funder types

Other

Identifiers

NCT03714191
QI-Tobacco Cessation

Details and patient eligibility

About

The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare & Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.

Enrollment

54,417 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All providers of patients at NYU Langone Health (including NYU Winthrop) who are identified as currents smokers, as documented in the social history of their patient chart, and are eligible to receive the best practice advisory for tobacco cessation.

Exclusion criteria

  • non smokers

Trial design

54,417 participants in 3 patient groups

Improved outcomes
Treatment:
Other: Patient Outcomes
Regulatory reminder
Treatment:
Other: Regulatory
Billing and documentation
Treatment:
Other: Billing documentation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems